Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F20ZN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,467 to AmerisourceBergen Drug Corp for the supply of Skyrizi 360 mg/2.4 ml on-body injectors. The contract, awarded on January 20, 2026, with a completion date of February 10, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating open and competitive procurement. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger indefinite delivery contract vehicle with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as a comprehensive global pharmaceutical support program enabling AmerisourceBergen to supply a diverse range of pharmaceutical products and medical supplies to military healthcare systems and other federal medical institutions worldwide.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement needs. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award of this Skyrizi delivery order reflects the vendor's established position as a preferred supplier within the DLA's pharmaceutical distribution network and its ability to meet federal procurement requirements through competitive solicitation.
Quick answers
Who was awarded contract SPE2DR26F20ZN?
SPE2DR26F20ZN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F20ZN worth?
The government has obligated $12,467 on SPE2DR26F20ZN.
Is contract SPE2DR26F20ZN an order under another contract?
Yes. SPE2DR26F20ZN is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20ZN competed?
The extent of competition for SPE2DR26F20ZN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award